These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24794108)

  • 21. Mammalian Dopa decarboxylase: structure, catalytic activity and inhibition.
    Bertoldi M
    Arch Biochem Biophys; 2014 Mar; 546():1-7. PubMed ID: 24407024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
    Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
    Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition.
    Suchaud V; Gavara L; Giraud F; Nauton L; Théry V; Anizon F; Moreau P
    Bioorg Med Chem; 2014 Sep; 22(17):4704-10. PubMed ID: 25087047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
    Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P
    Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
    Papadopoulos EI; Fragoulis EG; Scorilas A
    Gene; 2015 Jan; 554(2):174-80. PubMed ID: 25445287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure activity studies on the crinane alkaloid apoptosis-inducing pharmacophore.
    McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
    Nat Prod Commun; 2009 Apr; 4(4):483-8. PubMed ID: 19475990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity.
    Reymond MJ; Porter JC
    Endocrinology; 1982 Oct; 111(4):1051-6. PubMed ID: 6811255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles.
    Nguyen P; Oumata N; Soubigou F; Evrard J; Desban N; Lemoine P; Bouaziz S; Blondel M; Voisset C
    Eur J Med Chem; 2014 Jul; 82():363-71. PubMed ID: 24927056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
    Nair JJ; van Staden J
    Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF; Fernstrom JD
    Endocrinology; 1977 Aug; 101(2):469-74. PubMed ID: 560295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
    Koutalellis G; Stravodimos K; Avgeris M; Mavridis K; Scorilas A; Lazaris A; Constantinides C
    BJU Int; 2012 Sep; 110(6 Pt B):E267-73. PubMed ID: 22571720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the dopa decarboxylase gene of Manduca sexta and its suppression by 20-hydroxyecdysone.
    Hiruma K; Carter MS; Riddiford LM
    Dev Biol; 1995 May; 169(1):195-209. PubMed ID: 7750638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism-based inactivation of dopa decarboxylase by serotonin.
    Bertoldi M; Moore PS; Maras B; Dominici P; Voltattorni CB
    J Biol Chem; 1996 Sep; 271(39):23954-9. PubMed ID: 8798628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
    Foster SB; Wrona MZ; Han J; Dryhurst G
    Chem Res Toxicol; 2003 Oct; 16(10):1372-84. PubMed ID: 14565778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical studies on the pyridoxal-5'-phosphate dependent enzyme dopa decarboxylase: effect of thr 246 residue on the co-factor-enzyme binding and reaction mechanism.
    Chakrabarty K; Gupta SN; Das GK; Roy S
    Indian J Biochem Biophys; 2012 Jun; 49(3):155-64. PubMed ID: 22803330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
    Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
    Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells.
    Borelli MI; Villar MJ; Orezzoli A; Gagliardino JJ
    Diabetes Metab; 1997 Apr; 23(2):161-3. PubMed ID: 9137906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite sexual dimorphism of 3,4-dihydroxyphenylalanine decarboxylase in the kidney and small intestine of mice.
    López-Contreras AJ; Galindo JD; López-García C; Castells MT; Cremades A; Peñafiel R
    J Endocrinol; 2008 Mar; 196(3):615-24. PubMed ID: 18310457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lycorine derivatives against Trichomonas vaginalis.
    Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
    Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.